期刊文献+

甲酚红分光光度法测定替米沙坦的含量 被引量:1

Spectrophotometric Determination of Telmisartan by Its Reaction with Cresol Red
下载PDF
导出
摘要 在pH为6.60的B-R缓冲介质中,替米沙坦(TMST)与甲酚红反应生成离子缔合物。当以试剂空白作参比时,在572nm及428nm波长处分别有正、负吸收峰。测定在572nm处增色反应的吸光度或在428nm处褪色反应的吸光度均与TMST的浓度之间呈线性关系,可作为测定TMST的基础。在所提出的方法中采用572nm作为测定TMST的检测波长。在此条件下TMST的浓度在4.6×10-7~1.3×10-5 mol.L-1之间与所测吸光度呈线性关系,其表观摩尔吸光率为5.34×104L.mol-1.cm-1。应用此方法测定了TMST胶囊和片剂中TMST的含量,测定结果与标示量相符,测定值的相对标准偏差(n=11)均小于2.5%。 In B-R buffer medium of pH 6.6,an ion association complex was formed by the reaction between Telmisartan(TMST) and cresol red.When measuring against a reagent blank,a positive and a negative absorption maxima were found at the wavelengths of 572 nm and 428 nm respectively.Linear relationships between values of concentration of TMST and the absorbance were obtained either at 572 nm(the color-enhancing reaction) or at 428 nm(the color-fading reaction),on the base of which determination of TMST could be performed.In the proposed method,572 nm was selected as the measuring wavelength.Under this condition,linearity range was obtained between 4.6×10-7 and 1.3×10-5mol·L-1 of TMST,and the apparent molar absorptivity found was 5.34×104L·mol-1·cm-1.This method was used for determination of TMST in its capsules and tablets,giving results in comformity with the labelled values,and values of RSD′s(n=11) less than 2.5%.
出处 《理化检验(化学分册)》 CAS CSCD 北大核心 2012年第1期90-92,101,共4页 Physical Testing and Chemical Analysis(Part B:Chemical Analysis)
基金 重庆市教委科学技术项目(NO:KJ101314) 重庆市涪陵区科委科技计划项目(NO:2008-43)项目资助
关键词 分光光度法 替米沙坦 甲酚红 Spectrophotometry Telmisartan Cresol red
  • 相关文献

参考文献12

二级参考文献19

  • 1高玲,刘茜,赵怀清.反相高效液相色谱法测定替米沙坦片的含量[J].中国药事,2005,19(4):226-227. 被引量:1
  • 2秦宗会.氨基黑10B褪色光度法测定两种阳离子表面活性剂及其作用机理[J].理化检验(化学分册),2006,42(6):426-429. 被引量:9
  • 3秦宗会,汪正文,谭蓉.百里酚蓝分光光度法测定阿昔洛韦及其反应机理[J].理化检验(化学分册),2007,43(5):354-357. 被引量:6
  • 4秦宗会,谭蓉.用刚果红分光光度法测定阳离子表面活性剂[J].分析测试学报,2007,26(1):113-116. 被引量:11
  • 5MAESHIBA Y, KIYOTA Y, YAMASHITA K, et al. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys[J]. Arzneimittel- Forschung, 1997,47(1) : 29-35.
  • 6PATTANA S, PENPORN N, AURASORN S. High- performance liquid chromatographic method for the determinationof pioglitazone in human plasma using ultraviolet detection and its application to a pharmacokinetic study[J].Journal of Chromatography B, 2006, 843: 164-169.
  • 7SANE R T, MENON S N, SHAFI INAMDAR, et al. Simultaneous determination of pioglitazone and glimepiride by high-performance liquid chromatography[J].Chromatographia, 2004,59:451-453.
  • 8LIN Zhong-ping, JI Wei-hua, DAKSHA D K, et al. Simultaneous determination of pioglitazone and its two active metabolites in human plasma by LC/MS/MS[J].Journal of Pharmaceutical and Biomedical Analysis, 2003,33: 101-108.
  • 9EMMIE N M H, KENNETH C H Y, TERENCE S M W, et al. Detection of anti-diabetics in equine plasma and urine by liquid chromatography-tandem mass spectrometry[J]. Journal of Chromatography B, 2004,811:65-73.
  • 10McCleLlan KJ, Markham A. Telmisartan. Drugs, 1998,56 (6) : 1039.

共引文献31

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部